▎ 摘　　要

The present manuscript describes a simple, facile and effective solvothermal route to synthesize Fe3O4 nanoparticles (Fe3O4 NPs), reduced graphene oxide nanosheets (rGO NSs) and Fe3O4/reduced graphene oxide nanohybrid composite (Fe3O4/rGO nanohybrid composite) and subsequently examines their comparative biocompatibilities. The as-obtained Fe3O4 NPs, rGO NSs and Fe3O4/rGO nanohybrid composite have been characterized by X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM) and Raman spectroscopy. The XRD studies and scanning electron microscope confirmed the proper phase formation and the surface morphology of the as-synthesized products, respectively. The Raman spectra of Fe3O4 NPs show the strongest peak at 673 cm(-1) which can be assigned to A(1g) peak of bare Fe3O4 NPs and it complements the XRD studies. Furthermore, the increment in the I-D/I-G ratio in the Fe3O4/rGO nanohybrid composite suggests the creation of defects in graphene sheets due to strain caused by Fe3O4 NPs. The biocompatibility of these samples has been tested using Lung cancer cell line H1299 through MTT assay. The MTT assay reveals that the nanohybrid composite endows more biocompatible and effectiveness than rGO NSs and Fe3O4 NPs individually, as anti-proliferative agent for cancer treatment.